High-dose, long-term continuous intravenous octreotide infusion for recurrent carcinoid crises in atypical pulmonary carcinoid. A Case Report
Case Reports in Oncology · 17.11.2026
DOI: 10.1159/cro/abzag086 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Oncology, online erschienen am 17.11.2026. Verfasst von Lauren Di Salvo und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This case report details a unique clinical scenario of a patient with atypical pulmonary carcinoid who required long-term continuous intravenous octreotide infusions (CIOI) for the management of refractory carcinoid syndrome. Previously unreported, high-dose, prolonged CIOI (up to 1400 mcg/hour) was required to achieve symptom control over a six-year period. Majority of the treatment duration was delivered at home via the ‘Hospital in the Home’ service of the acute hospital. Due to the rarity of this scenario, there is a lack of evidence-based guidelines to inform the management of refractory carcinoid symptoms associated with metastatic pulmonary carcinoid. This case highlights both the utility of high-dose long-term CIOI, and its ability to be delivered at home by a skilled hospital-linked ‘Hospital in the Home’ service, which may benefit a select cohort of patients with similar severe refractory disease.
Zitieren
APA
Salvo, L. D., Fourlanos, S., Montalto, M., & Zimet, A. (2026). High-dose, long-term continuous intravenous octreotide infusion for recurrent carcinoid crises in atypical pulmonary carcinoid. A Case Report. Case Reports in Oncology. https://doi.org/10.1159/cro/abzag086
Vancouver
Salvo LD, Fourlanos S, Montalto M, Zimet A. High-dose, long-term continuous intravenous octreotide infusion for recurrent carcinoid crises in atypical pulmonary carcinoid. A Case Report. Case Reports in Oncology. 2026. doi:10.1159/cro/abzag086
BibTeX
@article{Salvo2026,
author = {Salvo, Lauren Di and Fourlanos, Spiros and Montalto, Michael and Zimet, Allan},
title = {High-dose, long-term continuous intravenous octreotide infusion for recurrent carcinoid crises in atypical pulmonary carcinoid. A Case Report},
journal = {Case Reports in Oncology},
year = {2026},
doi = {10.1159/cro/abzag086}
}
EUVIMED